Characteristic of a drug carrier for hepatocellular carcinoma (HCC)-selective targeting

Galactose can be specifically recognized by ASGPR. PEG-Gal-COS-CYPATE was constructed to target the drug to HCC cells. Due to steric hindrance of PEG, drugs will not bind to the normal liver cells to avoid damage.